Related Experiment Video

Updated: May 8, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Breaking down patient and physician barriers to optimize glycemic control in type 2 diabetes

Stuart A Ross1

  • 1University of Calgary, Calgary, AB, Canada. drross@telus.net

The American Journal of Medicine
|August 20, 2013
PubMed

Insights

Many patients with type 2 diabetes struggle to reach blood glucose targets due to treatment barriers. Addressing these issues with newer therapies and comprehensive care plans can improve glycemic control and patient outcomes.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Diabetes Management

Background:

  • Type 2 diabetes (T2D) affects a significant portion of the population, with many patients failing to meet therapeutic blood glucose targets.
  • Suboptimal glycemic control in T2D elevates the risk of severe diabetes-related complications and increases long-term healthcare expenditures.
  • Existing glucose-lowering therapies are diverse, yet patient outcomes remain suboptimal, highlighting systemic and patient-specific challenges.

Purpose of the Study:

  • To identify and analyze the key barriers preventing optimal glycemic control in patients with type 2 diabetes.
  • To explore how overcoming these barriers can lead to improved treatment outcomes and reduced complication risks.
  • To highlight the potential of novel therapeutic approaches and integrated care strategies in enhancing diabetes management.

Main Methods:

  • Literature review and synthesis of current research on T2D management and treatment adherence.
  • Analysis of factors contributing to physician and patient-level challenges in diabetes care.
  • Examination of the role of patient education and care planning in therapeutic success.

Main Results:

  • Key barriers include patient nonadherence, delayed therapy intensification by physicians, and systemic healthcare deficiencies.
  • Specific obstacles encompass treatment side effects, complex medication regimens, needle phobia, inadequate patient education, and lack of structured care plans.
  • Emerging therapies and devices, coupled with robust patient education and care coordination, show promise in mitigating these barriers.

Conclusions:

  • Overcoming barriers to glycemic control is crucial for improving treatment outcomes in type 2 diabetes.
  • A multifaceted approach integrating advanced therapies, patient education, and comprehensive care plans is essential for effective diabetes management.
  • Addressing patient and healthcare system factors can significantly enhance the achievement of blood glucose targets and reduce long-term diabetes complications.
Keywords:
Clinical inertiaGlycemic controlNonadherence

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...